2015
DOI: 10.1093/jamia/ocv053
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic software design for clinical exome and genome analyses: insights from bioinformaticians, clinical geneticists, and genetic counselors

Abstract: Background The transition of whole-exome and whole-genome sequencing (WES/WGS) from the research setting to routine clinical practice remains challenging.Objectives With almost no previous research specifically assessing interface designs and functionalities of WES and WGS software tools, the authors set out to ascertain perspectives from healthcare professionals in distinct domains on optimal clinical genomics user interfaces.Methods A series of semi-scripted focus groups, structured around professional chall… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 70 publications
0
10
0
Order By: Relevance
“…The workflows should also be assessed in terms of (a) performance with diseases that present with heterogeneous, overlapping, or novel phenotypes and (b) incorporation of information beyond gene level. In addition to the scope of the evaluation, the study recruitment was also restricted to medical/biochemical geneticists in order to ensure that participants represent a focused group of users, who would exhibit similar areas of attention/interest when approaching WES/WGS data as well as shared desiderata towards WES/WGS analysis software 37 . Further research should also consider inclusion of other healthcare professionals involved in clinical WES/WGS interpretation (eg, genetic counselors and bioinformaticians) to gain further insights into diverse groups of users and their interaction with different workflows.…”
Section: Discussionmentioning
confidence: 99%
“…The workflows should also be assessed in terms of (a) performance with diseases that present with heterogeneous, overlapping, or novel phenotypes and (b) incorporation of information beyond gene level. In addition to the scope of the evaluation, the study recruitment was also restricted to medical/biochemical geneticists in order to ensure that participants represent a focused group of users, who would exhibit similar areas of attention/interest when approaching WES/WGS data as well as shared desiderata towards WES/WGS analysis software 37 . Further research should also consider inclusion of other healthcare professionals involved in clinical WES/WGS interpretation (eg, genetic counselors and bioinformaticians) to gain further insights into diverse groups of users and their interaction with different workflows.…”
Section: Discussionmentioning
confidence: 99%
“…This allows an integrated display of QC information suitable for clinicians as suggested by Shyr, c.f. (23) . Finally, the user can consider this information for all samples in a project to evaluate a sample in comparison to similarly processed ones or for a whole cohort.…”
Section: Quality Control Functionalitymentioning
confidence: 99%
“…[4,[6][7][8] Diagnostic Decision Support Systems (DDSSs) are a key type of CDS needed in genomics to supplement a shortage of trained clinicians and address the inherent complexity of genomic diagnosis. [9,10] Complexity arises from the heterogeneous nature of genetic diseases, the variable expression in patients, and the degree of overlap in findings (i.e., signs, symptoms and test results) among genetic conditions, sometimes differentiated mainly by onset age of individual findings. [11] Systematic review and position statements note two needs from DDSSs in genomics:…”
Section: Background and Significancementioning
confidence: 99%